Gabapentin Capsule
Product Images NDC 70518-0293

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70518-0293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 300mg 70518 0293 00

Gabapentin 300mg 70518 0293 00
Gabapentin 300 mg is a prescription medication available in capsule form. The quantity provided is 90 capsules. The medication is manufactured by Ascend Labs, LLC and sourced from NDC number 67877-0223-05. The expiration date is not provided. The medication should be stored at a temperature between 20-25°C (or 68-77°F), with excursions permitted to 15-30°C (or 59-86°F). It is important to keep this medication out of reach of children. Directions for use should be followed as indicated in the package insert. The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA.*
FDA Label Image

Mm2 (Gabapentin 300mg 70518 0293 01)

FDA Label Image

Mm3 (Gabapentin 300mg 70518 0293 02)

FDA Label Image

Mm4 (Gabapentin 300mg 70518 0293 03)

Mm4 (Gabapentin 300mg 70518 0293 03)
This is a description of a medication called Gabapentin in capsule form with a strength of 300 mg. The medication is manufactured by Ascend Labs, LLC in Montvale, NJ. It is important to keep this medication out of the reach of children. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (83-77°F) with excursions permitted up to 15-30°C (53-86°F) as per USP standards. It has been repackaged by RemedyRepack Inc. in Indiana, PA. Contact information for RemedyRepack Inc. is provided as 724.455.8762.*
FDA Label Image

Mm5 (Gabapentin 300mg 70518 0293 04)

Mm5 (Gabapentin 300mg 70518 0293 04)
This is a description of a medication called Gabapentin. It is a capsule containing 300 mg of the active ingredient. The package contains 180 capsules. The manufacturer is Ascend Labs, LLC located in Montvale, NJ 07645. It is important to keep this medication out of the reach of children. The medication should be stored at a temperature of 20-25°C (83-77°F) with excursions permitted between 15-30°C (53-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc., located in Indiana, PA 15701. For detailed instructions on how to use the medication, please refer to the package insert.*
FDA Label Image

Mm6 (Gabapentin 300mg 70518 0293 05)

FDA Label Image

Mm7 (Gabapentin 300mg 70518 0293 06)

Mm7 (Gabapentin 300mg 70518 0293 06)
This is a description of a medication called Gabapentin. It is a capsule containing 300 mg of the active ingredient. The medication is manufactured by Ascend Labs, LLC located in Montvale, NJ 07645. The NDC (National Drug Code) number for this medication is 70518-0293-06. It has an expiration date but the exact date is not provided. The medication should be stored at a temperature between 20-25°C (83-77°F), with excursions permitted to 15-30°C (53-86°F) according to USP guidelines. This medication is repackaged by RemedyRepack Inc. located in Indiana, PA 15701. It is important to keep this medication out of the reach of children. Further directions for use can be found in the package insert.*
FDA Label Image

Gabapentin-equation (Gabapentin Equation)

FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
Mean Pain Score: 10 This text appears to represent a graph or chart displaying a mean pain score. The exact context and details are not clear due to the quality. However, it seems to show two periods: a 4-week dose titration period and a 4-week fixed dose period. The graph likely compares the pain scores between a placebo group and a group taking 3600 mg/day of Gabapentin. The baseline data is not available.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

FDA Label Image

Gabapentin-fig4 (Gabapentin Fig4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.